Status: Recruiting
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
This is a randomized Phase II study of intermittent versus continuous venetoclax therapy with Acalabrutinib in previously untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Participants needed: 62
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Zulfa OmerUpdated: Jan 6, 2026Locations: 1
Eligibility criteria
Diagnosis of Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (S... [+12]
Evidence of any active concurrent disease (such as severe or uncontrolled system... [+25]